FibroGen Inc (FGEN)’s financial ratios: A comprehensive overview

In the latest session, FibroGen Inc (NASDAQ: FGEN) closed at $1.30 down -4.41% from its previous closing price of $1.36. On the day, 1139871 shares were traded.

Ratios:

For a deeper understanding of FibroGen Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.33 and its Current Ratio is at 1.52.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2023, Downgraded its rating to Underperform and sets its target price to $2 from $4 previously.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 ’24 when Wettig Thane bought 50,000 shares for $1.91 per share. The transaction valued at 95,470 led to the insider holds 470,178 shares of the business.

Henderson Jeffrey William sold 2,000 shares of FGEN for $2,060 on Sep 01 ’23. The Director now owns 28,866 shares after completing the transaction at $1.03 per share. On Aug 04 ’23, another insider, Henderson Jeffrey William, who serves as the Director of the company, sold 2,000 shares for $1.91 each. As a result, the insider received 3,820 and left with 30,866 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.87.

Stock Price History:

Over the past 52 weeks, FGEN has reached a high of $20.90, while it has fallen to a 52-week low of $0.33.

Shares Statistics:

A total of 98.77M shares are outstanding, with a floating share count of 91.83M. Insiders hold about 7.02% of the company’s shares, while institutions hold 71.23% stake in the company.

Earnings Estimates

There are Agenus Inc. different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $22.99, with high estimates of $20.93 and low estimates of $2.13.

Most Popular

[the_ad id="945"]